Clinical trial
Clinical Study of Fluzopalil Combined With Apatinib for Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
NCT06188455 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Fluzopalil Combined With Apatinib for Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- December 1, 2024
- Completion date
- December 1, 2026
- Enrollment
- 37 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer